News

February 28, 2024

Longtime Gilead Commercial Executive Joins IntegriChain as Chairman of the Board

IntegriChain appoints Jim Meyers, a highly experienced pharmaceutical commercialization executive, as Chairman of the Board. Meyers offers more than 35 years of industry experience, from his more than two decades at Gilead Sciences where he served as Chief Commercial Officer and EVP of Worldwide Commercial Operations to his leadership in emerging biopharma as a board member for a broad spectrum of clinical-stage companies.





November 30, 2023

IntegriChain GTN Experts to Speak at Informa’s Pharma/BioTech GTN Summit

Philadelphia, PA, November 13, 2023 – IntegriChain, delivering pharma’s only comprehensive technology, data, consulting, and outsourcing platform for data-driven commercialization, today announced that its Gross-to-Net (GTN) experts will present at Informa’s upcoming Pharma | Biotech GTN Summit. Jen Sharpe, Vice President of Gross-to-Net Operational Consulting and facilitator of the Revenue Analytics Collaborative, and Jeff Baab, Vice President of Operational Consulting, have extensive experience in GTN automation, advising Pharma manufacturers of all sizes, business stages, and complexity on SaaS and BPaaS solutions for GTN forecasting, accruals, and analytics. Jen Sharpe is Chairperson and IntegriChain is a sponsor of the conference, which […]






adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article